Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 7
2006 4
2007 2
2008 5
2009 6
2010 7
2011 17
2012 9
2013 12
2014 9
2015 10
2016 9
2017 4
2018 11
2019 9
2020 10
2021 12
2022 4
2023 3
2024 5
2025 6
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Effect of azithromycin on bronchiolitis obliterans syndrome in posttransplant recipients: A systematic review and meta-analysis.
Hao X, Peng C, Lian W, Liu H, Fu G. Hao X, et al. Medicine (Baltimore). 2022 Jul 15;101(28):e29160. doi: 10.1097/MD.0000000000029160. Medicine (Baltimore). 2022. PMID: 35839027 Free PMC article.
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a devastating complication that occurs after transplantation. Although azithromycin is currently used for the treatment of BOS, the evidence is sparse and controversial. ...
BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a devastating complication that occurs after transplantation. Although …
Long-term effect of azithromycin in bronchiolitis obliterans syndrome.
Gan CT, Ward C, Meachery G, Lordan JL, Fisher AJ, Corris PA. Gan CT, et al. BMJ Open Respir Res. 2019 Oct 15;6(1):e000465. doi: 10.1136/bmjresp-2019-000465. eCollection 2019. BMJ Open Respir Res. 2019. PMID: 31673366 Free PMC article. Clinical Trial.
INTRODUCTION: Azithromycin stabilises and improves lung function forced expiratory volume in one second (FEV(1)) in lung transplantation patients with bronchiolitis obliterans syndrome (BOS). A post hoc analysis was performed to assess the long-term effect of …
INTRODUCTION: Azithromycin stabilises and improves lung function forced expiratory volume in one second (FEV(1)) in lung transplantat …
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, Van Raemdonck DE, Dupont LJ, Verleden GM. Vanaudenaerde BM, et al. Eur Respir J. 2008 Oct;32(4):832-43. doi: 10.1183/09031936.00134307. Eur Respir J. 2008. PMID: 18827151 Free article. Review.
Bronchiolitis obliterans syndrome (BOS) is the most important cause of late mortality following lung transplantation, resulting in major morbidity and a huge burden on healthcare resources. ...The acceptance of this dichotomy can improve understanding of the heterog …
Bronchiolitis obliterans syndrome (BOS) is the most important cause of late mortality following lung transplantation, resultin …
Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis.
Kingah PL, Muma G, Soubani A. Kingah PL, et al. Clin Transplant. 2014 Aug;28(8):906-10. doi: 10.1111/ctr.12401. Epub 2014 Jul 9. Clin Transplant. 2014. PMID: 24931185
INTRODUCTION: Azithromycin has been shown to reverse or halt the decline of forced expiratory volume in one s (FEV1) in patients with bronchiolitis obliterans (BOS) syndrome following lung transplant. ...It remains uncertain whether this improvement stays aft …
INTRODUCTION: Azithromycin has been shown to reverse or halt the decline of forced expiratory volume in one s (FEV1) in patients with …
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults.
Bos S, Murray J, Marchetti M, Cheng GS, Bergeron A, Wolff D, Sander C, Sharma A, Badawy SM, Peric Z, Piekarska A, Pidala J, Raj K, Penack O, Kulkarni S, Beestrum M, Linke A, Rutter M, Coleman C, Tonia T, Schoemans H, Stolz D, Vos R. Bos S, et al. Eur Respir J. 2024 Mar 28;63(3):2301727. doi: 10.1183/13993003.01727-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38485149 Free article.
The purpose of this joint European Respiratory Society (ERS) and European Society for Blood and Marrow Transplantation task force was to develop evidence-based recommendations regarding the treatment of pulmonary cGvHD phenotype bronchiolitis obliterans syndrome in …
The purpose of this joint European Respiratory Society (ERS) and European Society for Blood and Marrow Transplantation task force was to dev …
Azithromycin in acute bronchiolitis.
Solé D, Matsumoto F, Wandalsen GF. Solé D, et al. J Bras Pneumol. 2020;46(3):e20200285. doi: 10.36416/1806-3756/e20200285. Epub 2020 Jul 6. J Bras Pneumol. 2020. PMID: 32638841 Free PMC article. No abstract available.
Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.
Fietta AM, Meloni F. Fietta AM, et al. Curr Med Chem. 2008;15(7):716-23. doi: 10.2174/092986708783885228. Curr Med Chem. 2008. PMID: 18336286 Review.
Bronchiolitis obliterans syndrome (BOS) is the leading cause of death in lung transplant recipients (LTR). ...Long-term oral azithromycin therapy can significantly improve FEV1 in about 42% of patients with established BOS. ...
Bronchiolitis obliterans syndrome (BOS) is the leading cause of death in lung transplant recipients (LTR). ...Long-term oral …
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, Giebel S, Greinix H, Holler E, Lawitschka A, Mielke S, Mohty M, Arat M, Nagler A, Passweg J, Schoemans H, Socié G, Solano C, Vrhovac R, Zeiser R, Kröger N, Basak GW. Penack O, et al. Lancet Haematol. 2020 Feb;7(2):e157-e167. doi: 10.1016/S2352-3026(19)30256-X. Lancet Haematol. 2020. PMID: 32004485 Review.
Key updates to these recommendations include a broader use of rabbit anti-T-cell globulin; lower steroid doses for the management of grade 2 acute GVHD with isolated skin or upper gastrointestinal tract manifestations; fluticasone, azithromycin, and montelukast should be u …
Key updates to these recommendations include a broader use of rabbit anti-T-cell globulin; lower steroid doses for the management of grade 2 …
Azithromycin and bronchiolitis obliterans.
Kanazawa S, Nomura S, Muramatsu M, Yamaguchi K, Fukuhara S. Kanazawa S, et al. Am J Respir Crit Care Med. 2004 Mar 1;169(5):654-5; author reply 655. doi: 10.1164/ajrccm.169.5.952. Am J Respir Crit Care Med. 2004. PMID: 14982826 No abstract available.
148 results